RedHill Biopharma (RDHL) Times Interest Earned (2016 - 2023)
Historic Times Interest Earned for RedHill Biopharma (RDHL) over the last 12 years, with Q2 2023 value amounting to $27.91.
- RedHill Biopharma's Times Interest Earned rose 118405.85% to $27.91 in Q2 2023 from the same period last year, while for Jun 2023 it was -$1.2, marking a year-over-year increase of 8069.87%. This contributed to the annual value of -$7.1 million for FY2024, which is 54043268443.75% down from last year.
- As of Q2 2023, RedHill Biopharma's Times Interest Earned stood at $27.91, which was up 118405.85% from -$69.07 recorded in Q1 2023.
- RedHill Biopharma's Times Interest Earned's 5-year high stood at $167.3 during Q2 2019, with a 5-year trough of -$69.07 in Q1 2023.
- Its 5-year average for Times Interest Earned is $15.0, with a median of $4.29 in 2020.
- Its Times Interest Earned has fluctuated over the past 5 years, first surged by 290564.47% in 2019, then plummeted by 172372.26% in 2023.
- Quarter analysis of 5 years shows RedHill Biopharma's Times Interest Earned stood at $62.91 in 2019, then crashed by 93.12% to $4.33 in 2020, then plummeted by 987.5% to -$38.41 in 2021, then grew by 20.52% to -$30.53 in 2022, then skyrocketed by 191.42% to $27.91 in 2023.
- Its Times Interest Earned was $27.91 in Q2 2023, compared to -$69.07 in Q1 2023 and -$30.53 in Q4 2022.